AzTrials
AzTrials

Mental Health DisorderSAIA-MHNCT05103033

Systems Analysis and Improvement Approach to Optimize the Task-shared Mental Health Treatment Cascade (SAIA-MH)

A study testing Systems Analysis and Improvement Approach for Mental Health (SAIA-MH) in people with Mental Health Disorder, run by University of Washington at 16 sites in Mozambique.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The purpose of this study is to test the effectiveness of a multicomponent implementation strategy entitled the Systems Analysis and Improvement Approach for mental health (SAIA-M) using a cluster randomized trial at the health facility level. Read more about this study

Who is it for?
Any age
Conditions the study is for
Mental Health Disorder
What is being tested?
Systems Analysis and Improvement Approach for Mental Health (SAIA-MH)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
155 participants
Where
16 sitesMozambique
Study dates
14 Mar 2022to 30 Jan 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • 1. Patient diagnosed with a mental health condition in outpatient primary care, prescribed a medication, and given a follow-up date.
  • Mental health workers currently working and collaborating on the treatment of outpatient mental health patients in target clinics in Sofala or Manica provinces, Mozambique.
  • Mental health workers must be employed by Ministry of Health.
  • Mental health managers or directors currently supervising mental health workers who are leading treatment of outpatient mental health patients in target clinics in Sofala or Manica provinces, Mozambique. Must be employed by the Ministry of Health.

Who cannot join

  • Patient enrolled in treatment outside of targeted mental health systems analysis and improvement approach (SAIA-MH) facilities.
  • Patients not prescribed a medication.
  • Patients not given a follow-up date.
  • 1. Health worker not involved in outpatient mental healthcare delivery. Health worker not employed by the Ministry of Health.

Trial locations and contacts

16 sites in 1 country.

16 sites in 1 country

Mozambique16 sites
  • Urban Health Center Chingussura

    Beira, Sofala

  • Urban Health Center Inhamizua

    Beira, Sofala

  • Urban Health Center Macurungo

    Beira, Sofala

  • Urban Health Center Mascarenhas

    Beira, Sofala

  • District Hospital Catandica

    Catandica, Manica Province

  • Hospital Muxúngue

    Chibabava, Sofala

  • Urban Health Center Nhamaonha

    Chimoio, Manica Province

  • Urban Health Center Vila Nova

    Chimoio, Manica Province

  • Rural Health Center Mafambisse

    Dondo, Sofala

  • Urban Health Center Dondo Sede

    Dondo, Sofala

  • District Hospital Gondola

    Gondola, Manica Province

  • Rural Health Center Macate

    Macate, Manica Province

  • District Hospital Manica

    Manica

  • Rural Hospital Nhamatanda

    Nhamatanda, Sofala

  • Rural Health Center Sussundenga Sede

    Sussundenga, Manica Province

  • Rural Health Center Vanduzi

    Vanduzi, Manica Province

Other trials in Mozambique

About this study

Official title: Systems Analysis and Improvement Approach to Optimize the Task-shared Mental Health Treatment Cascade (SAIA-MH): A Cluster Randomized Trial

The purpose of this study is to test the effectiveness of a multicomponent implementation strategy entitled the Systems Analysis and Improvement Approach for mental health (SAIA-M) using a cluster randomized trial at the health facility level. SAIA-MH focuses on improving the mental health treatment cascade in primary outpatient mental healthcare. The mental health treatment cascade is a model that outlines the sequential, linked treatment steps that people with mental illness must navigate, from initial diagnosis to symptom/function improvement.

This study will also assess the potential mechanisms by which the SAIA-MH implementation strategy works, or does not work, along with the cost and effectiveness of scaling-up SAIA-MH in Mozambique.

Read the detailed description

Due to a shortage of 1.2 million mental health (MH) workers across low- and middle-income countries (LMICs), academic and policy leaders have advocated scaling-up task-sharing to lower-level providers to close the mental health care gap, which exceeds 90% in many LMICs. While task-sharing may increase access to care, limited attention has been paid to quality of care provided by lower-level providers. Task-shared outpatient management of mental health in Mozambique has shown low rates of retention in care (40%), medication adherence (<15%), and proportion of patients achieving function improvement (<5%). Similarly high rates of loss-to-follow-up, poor adherence, and poor patient outcomes have been reported across other LMICs. To our knowledge, there are no evidence-based implementation strategies targeting optimization of the MH treatment cascade in low-resource settings. This is an urgent need for the field of MH care delivery globally.

The MH treatment cascade is a model that outlines the sequential, linked treatment steps that people with mental illness must navigate, from initial diagnosis to symptom/function improvement. Quality problems in one step of a treatment cascade can have non-linear and compounding impacts across the larger complex care system. Implementation strategies focused on only one step in a cascade can potentially contribute to unintended system bottlenecks and quality of care issues. By contrast, the "Systems Analysis and Improvement Approach (SAIA)" is a multicomponent implementation strategy focused on optimizing an entire treatment cascade. SAIA blends facilitation, enhanced local clinical consultation, and the creation of facility-level learning collaboratives with systems-engineering tools in a 5-step approach specifically developed for task-shared providers, which include: (1) cascade analysis to visualize treatment cascade drop-offs and prioritize areas for system improvements; (2) process mapping to identify modifiable facility-level bottlenecks; (3) identification and implementation of modifications to improve system performance; (4) assessment of modification effects on the cascade; and (5) repeated analysis and improvement cycles. A previous cluster RCT established effectiveness of SAIA for HIV treatment cascade improvement (R01HD075057; PI: Sherr). However, no effectiveness data exist on SAIA applied to other complex treatment cascades - such as task-shared MH care. Preliminary data suggest that applying SAIA to MH treatment cascade optimization (SAIA-MH; R21MH113691; PI: Wagenaar) is feasible, acceptable, and can result in clinically-significant treatment cascade improvements; Five months of SAIA-MH implementation resulted in a 1.5-fold increase in medication adherence (aOR: 1.5; CI: 1.2, 1.9) and a 3.7-fold increase in function improvement (aOR: 3.7; CI: 2.5, 5.4). These data suggest that SAIA-MH is a promising strategy for task-shared MH systems improvement globally. Our specific aims are to:

Primary Aim 1: Test the effectiveness of the SAIA-MH strategy using a pragmatic cluster RCT design and assess determinants of implementation success. The investigators will implement SAIA-MH using a 3-year parallel cluster RCT across 8 intervention and 8 attentional control facilities and evaluate effects on mental health function improvement (primary) and retention / medication adherence (secondary). Two years of study implementation will be followed by a 1-year maintenance phase to examine routine fidelity and sustainability. The Consolidated Framework for Implementation Research (CFIR) will be used to assess determinants of implementation success.

Secondary Aim 1: Test causal pathway models to analyze mechanisms of action for effects (or non-effects) of the SAIA-MH implementation strategy. Using 3-years of monthly data on strategy-mechanism linkages, moderators, preconditions, and outcomes for the full 8 intervention and 8 attentional control facilities, the investigators will examine causal pathway effect estimates using longitudinal structural equation modeling. Qualitative CFIR data from Primary Aim 1 will contextualize quantitative path analyses.

Specific Aim 2: Estimate the cost and cost-effectiveness of scaling-up SAIA-MH in Mozambique. The investigators will conduct micro-costing and time-and-motion observation of the SAIA-MH RCT to estimate costs of implementing the intervention. The investigators will construct a Markov model parameterized with cost and outcome data from the SAIA-MH RCT to project budget impact and cost-effectiveness for SAIA-MH scale-up to provincial and national levels.

Being tested
Systems Analysis and Improvement Approach for Mental Health (SAIA-MH), Attentional Placebo Control
Keywords
Outpatient primary care
Medical subject headings
Mental Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Systems Analysis and Improvement Approach for Mental Health (SAIA-MH)Behavioural

    The 5 steps of SAIA-MH include: (1) cascade analysis to visualize treatment cascade drop-offs and prioritize areas for system improvements; (2) process mapping to identify modifiable facility-level bottlenecks; (3) identification and implementation of modifications to improve system performance; (4) assessment of modification effects on the cascade; and (5) repeated analysis and improvement cycles.

  • Attentional Placebo ControlBehavioural

    Facilities randomized to attentional placebo control will attend a 1-week in-person training which will include the same minimum staff above for SAIA-MH. This training will focus on reviewing data collection tools, ethics, mental health stigma and burnout for mental health professionals. Following the 1-week in person training, attentional placebo control facilities will receive regular supervision following the same schedule as SAIA-MH focused on reviewing data collection tools.

Study groups in NCT05103033
Study groupRoleWhat they receive
Systems Analysis and Improvement Approach (SAIA) for mental healthExperimentalThose receiving SAIA-MH will attend a 1-week in-person training for facility learning collaboratives. Following the 1-week in-person training, SAIA-MH standard operating procedures will be implemented, including: (1) structured internal/external facilitation following tablet-based guides used in pilot study (1x per week first month; 2x per week for next two months; 1x per month for remainder); (2) facilitation in the 5-step SAIA-MH improvement process.
Receives: Behavioral: Systems Analysis and Improvement Approach for Mental Health (SAIA-MH)
Attentional Placebo ControlOtherControl facilities will mimic activities of the intervention group in time and contacts, but without the "active ingredient" of the SAIA-MH implementation strategy
Receives: Behavioral: Attentional Placebo Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Function Improvement

    Patient function improvement is evaluated for all patients diagnosed with a mental disorder, prescribed a medication, given a follow-up date, and who return at least once. All patients diagnosed with a mental disorder in target clinics will have function improvement measured by the WHODAS 2.0 at each clinic visit.

    Improvement will be determined as patients with at least 1 follow-up visits who score less than 10 on the WHODAS 2.0 or have a 50% reduction in their baseline WHODAS 2.0 score.

    Measured: data collection will occur over 6 months baseline, 24-month intervention and 12-month sustainment period

Secondary outcomes (2)
  1. Patient Retention

    Patient retention is evaluated for all patients diagnosed with a mental disorder, prescribed a medication, given a follow-up date, and who return at least once. This outcome evaluates whether these individuals returned for their scheduled follow-up visit in less than or equal to 30 days.

    Measured: data collection will occur over 6 months baseline, 24-month intervention and 12-month sustainment period

  2. Patient Medication Adherence

    Medication adherence is evaluated for all patients diagnosed with a mental disorder, prescribed a medication, given a follow-up date, and who return at least once. These patients are considered to have potentially achieved medication adherence if they return for their follow-up visit and medication refill in less days than they had pills dispensed at their previous visit.

    Measured: data collection will occur over 6 months baseline, 24-month intervention and 12-month sustainment period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2021
  2. Study start14 Mar 2022
  3. Primary completion14 Oct 2024
  4. Study completion30 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
155 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05103033
Sponsor's protocol ID
STUDY00012527
Other IDs
1R01MH123682-01A1
Acronym
SAIA-MH
Status last verified
Jan 2026
First submitted
20 Oct 2021
Last updated
15 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Cumbe VFJ, Muanido A, Turner M, Jala JN Jr, Armando EE, Faduque F, Xerinda ER, Sherr K, Flaherty BP, Sharma M, Wagenaar BH. Effectiveness of the Systems Analysis and Improvement Approach to optimise outpatient mental, neurological, and substance-use disorder treatment cascades in Mozambique: a cluster-randomised trial. Lancet Psychiatry. 2026 Apr;13(4):316-326. doi: 10.1016/S2215-0366(26)00034-9.

    PubMed 41862257
  • Turner M, Muanido A, Cumbe V, Jala JN Jr, Armando EE, Mambuque E Jr, Faduque F, Xerinda ER, Sherr K, Weiner BJ, Flaherty BP, Sharma M, Wagenaar BH. Mental health care cascade performance and associated factors: longitudinal analyses of routine Ministry of Health services in Mozambique. BMJ Public Health. 2025 Mar 13;3(1):e001024. doi: 10.1136/bmjph-2024-001024. eCollection 2025.

    PubMed 40099137
  • Cumbe VFJ, Muanido AG, Turner M, Ramiro I, Sherr K, Weiner BJ, Flaherty BP, Sharma M, Faduque F, Xerinda ER, Wagenaar BH. Systems analysis and improvement approach to optimize outpatient mental health treatment cascades in Mozambique (SAIA-MH): study protocol for a cluster randomized trial. Implement Sci. 2022 Jun 6;17(1):37. doi: 10.1186/s13012-022-01213-8.

    PubMed 35668423

Questions about this trial

What is this clinical trial studying?

A study testing Systems Analysis and Improvement Approach for Mental Health (SAIA-MH) in people with Mental Health Disorder, run by University of Washington at 16 sites in Mozambique.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 15 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 16 sites in Mozambique. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Function Improvement (time frame: data collection will occur over 6 months baseline, 24-month intervention and 12-month sustainment period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05103033, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in